German pharma companies are meeting the corona "stress test"
.jpg)
The head of the leading German pharmaceutical industry organization says German firms are working top-speed to find coronavirus medications.
Amidst the coronavirus pandemic people in many countries worry whether too many crucial elements in their healthcare systems have been outsourced, in particular to China. In an interview with Germany Trade & Invest, Han Steutel, the president of the German Association of Research-Based Pharmaceutical Companies (VfA), has said he believes that's not a concern for German pharma.
"Germany is one of the world's strongest production locations where innovative, patented medications are concerned," Steutel explained. "Even amidst the stress test of the corona pandemic, Germany has remained capable of delivering and has exported significantly more patented medical products to China than it has imported from that country."
Death rates from Sars-CoV-2, the respiratory disease caused by the coronavirus, are far lower in Germany than almost everywhere else in the world. The VfA says German expertise is hard at work in all areas of the fight against corona-related ailments.
"There are around 60 companies and institutes working at top speed on vaccines," said Steutel. "Several dozens of existing medications are being tested to see if they can help corona patients. And a series of new medications are being developed, mostly on the basis of antibodies. German companies and institutes are part of all three efforts."
Steutel added that Germany's 44 researched-based pharmaceutical companies were cooperating internationally and with biotech firms in the search for corona medications.
Related News
-
News Women in Pharma: Unlocking patient inclusion at CPHI Americas
Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can towards making the healthcare industry and workplace more equitable and inclusive.&nbs... -
News Tracking Innovation with Thermo Fisher Scientific: CPHI Americas Track Sponsor interview
As we gear up for CPHI Americas from May 20-22, 2025 at the Philadelphia Convention Center, we sat down with Track Sponsor Thermo Fisher Scientific to discuss the future of bioproduction in pharma.
-
News Welcome back to the CPHI Exhibitor Spotlight!
We’re continuing our journey through the standout companies heading to CPHI Americas 2025, and next up is Adare - a global leader known for turning complex formulation challenges into innovative, patient-centric solutions.
-
News PhRMA trade association issues comments on Section 232 investigation
The Pharmaceutical Research and Manufacturers of America (PhRMA), an American trade association representing groups in the pharmaceutical industry, issued a letter on May 6, 2026 to the Department of Commerce regarding the Section 232 National Security... -
News Pharmaceutical Packaging Market Prospects: Shifting regional policies
The pharmaceutical packaging industry is experiencing significant transformation in 2025, driven by regulatory changes, supply chain challenges, and sustainability initiatives. The US BIOSECURE Act, passed through the House of Representatives in Septem... -
News Executive order to elevate US pharma manufacturing signed by Trump
On Monday, May 5, US President Trump signed an executive order to reduce regulatory barriers for domestic US pharmaceutical manufacturing, including key ingredients and materials for manufacturing prescription drugs.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News China import tax fine could cost AstraZeneca up to US$8 million
British-Swedish drugmaker AstraZeneca could find itself facing fines of up to US$8million in China due to suspected unpaid import taxes on breast cancer drug Enhertu.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance